Dimerix Limited (AU:DXB) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Dimerix Limited is set to host a webinar on November 6, 2024, to discuss initial findings from Project PARASOL, which aims to advance FSGS treatment by exploring new biomarker-based endpoints. This initiative could potentially accelerate approval pathways for FSGS therapies, addressing a significant need in the market with no currently approved treatments. The webinar is expected to attract interest from stakeholders keen on the latest developments in kidney disease research.
For further insights into AU:DXB stock, check out TipRanks’ Stock Analysis page.